ustekinumab-aekn
Generic: ustekinumab-aekn
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
ustekinumab-aekn
Generic Name
ustekinumab-aekn
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ustekinumab-aekn 45 mg/.5mL
Manufacturer
Identifiers & Regulatory
Product NDC
51759-413
Product ID
51759-413_ce170247-5614-44bc-88e0-89f515d9d8be
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761343
Listing Expiration
2027-12-31
Marketing Start
2025-12-23
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51759413
Hyphenated Format
51759-413
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ustekinumab-aekn (source: ndc)
Generic Name
ustekinumab-aekn (source: ndc)
Application Number
BLA761343 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 45 mg/.5mL
Packaging
- 1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "ce170247-5614-44bc-88e0-89f515d9d8be", "openfda": {"unii": ["FU77B4U5Z0"], "rxcui": ["2705393", "2705400"], "spl_set_id": ["052a3fb2-21c3-4c4e-a01e-afdd1accd1cd"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 TRAY / .5 mL in 1 SYRINGE, GLASS", "package_ndc": "51759-413-32", "marketing_start_date": "20251223"}], "brand_name": "Ustekinumab-aekn", "product_id": "51759-413_ce170247-5614-44bc-88e0-89f515d9d8be", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-12 Antagonist [EPC]", "Interleukin-12 Antagonists [MoA]", "Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "51759-413", "generic_name": "ustekinumab-aekn", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ustekinumab-aekn", "active_ingredients": [{"name": "USTEKINUMAB-AEKN", "strength": "45 mg/.5mL"}], "application_number": "BLA761343", "marketing_category": "BLA", "marketing_start_date": "20251223", "listing_expiration_date": "20271231"}